17 Non-controlling interests
2019 | 2018 | ||||
Andre Pectin | Yimante | Other | Total | Total | |
% of non-controlling interest | 25% | 25% | |||
Balance at 1 January | - | - | 33 | 33 | 103 |
|---|---|---|---|---|---|
Changes: | |||||
| 2 | - | 4 | 6 | 2 |
| 32 | 25 | - | 57 | (1) |
| - | - | 9 | 9 | (67) |
| 1 | - | - | 1 | - |
| - | - | (4) | (4) | (3) |
| - | - | 2 | 2 | (1) |
Total changes | 35 | 25 | 11 | 71 | (70) |
Balance at 31 December | 35 | 25 | 44 | 104 | 33 |
Acquisitions are related to the consolidation of Andre Pectin, due to the acquisition of an additional 46.05% of the shares and gain of control on 1 January 2019, and the acquisition of 75% of Yimante Health Ingredients (the vitamin E business of Nenter). See also Note 3 'Change in the scope of the consolidation'.
'Other consolidation changes' relates to the increase of DSM's share in DSM-NIAGA from 51% to 100%.
Not fully-owned subsidiaries on a 100% basis
2019 | 2018 | ||||
Andre Pectin | Yimante | Other | Total | ||
Assets | |||||
Intangible assets | 70 | 28 | 32 | 130 | 34 |
Property, plant and equipment | 48 | 57 | 178 | 283 | 173 |
Other non-current assets | - | 22 | 35 | 57 | 27 |
Inventories | 34 | 15 | 27 | 76 | 27 |
Receivables | 16 | 31 | 52 | 99 | 60 |
Cash and cash equivalents | 5 | 1 | 35 | 41 | 20 |
Total assets | 173 | 154 | 359 | 686 | 341 |
Liabilities | |||||
Provisions (non-current) | 15 | 2 | 2 | 19 | 2 |
Borrowings (non-current) | 1 | 38 | 25 | 64 | 14 |
Other non-current liabilities | - | 2 | 17 | 19 | 20 |
Borrowings and financial derivatives (current) | 3 | - | 72 | 75 | 79 |
Other current liabilities | 13 | 11 | 107 | 131 | 90 |
Total liabilities | 32 | 53 | 223 | 308 | 205 |
Net assets (100% basis) | 141 | 101 | 136 | 378 | 136 |
Net sales | 58 | - | 162 | 220 | 157 |
Profit for the year | 9 | (1) | 8 | 16 | 7 |
Operating cash flows | (4) | (16) | (35) | (55) | 86 |